Circio
About
Circio is a leading circular RNA biotech based in Norway and Sweden. Circio is developing a novel circular RNA-based gene expression platform, circVec, for next generation gene and cell therapies. The lead programs are in gene therapy for heart, eye and CNS disases and in vivo CAR-T cell therapy.
Areas of Activity
Biotech / Pharma
Therapeutic areas
Cardiology/Vascular DiseasesGenetic DiseaseImmunologyNeurologyOphthalmologyRare Disease
Phase of our company
Preclinical research
We are looking for
Public equity investorPharma innovation scouts & licensing
Representatives
CEO
Circio
CSO
Circio